Tel HaShomer Medical Research Infrastructure and Services Ltd.
发明人:
Anat Achiron,Roi Mashiach,Michael Gurevich
申请号：
US15996544
公开号：
US20180264002A1
申请日:
2018.06.04
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases.
